Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Chemotherapy often causes hair loss, so patients should be counseled to reduce anxiety.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Scalp cooling can help prevent hair loss from chemotherapy without raising cancer spread risk.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.